Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: G
Results 61 - 70 of 306 shown below

  • gastro-oesophageal junction

    A D'Errico, C Barozzi, M Fiorentino, R Carella, M Di Simone, L Ferruzzi, S Mattioli and W F Grigioni

    Role and new perspectives of transforming growth factor-alpha (TGF- alpha) in adenocarcinoma of the gastro-oesophageal junction

    doi:10.1054/bjoc.1999.1013

  • gastro-oesophageal reflux

    W Ye, W-H Chow, J Lagergren, P Boffetta, G Boman, H-O Adami and O Nyrén

    Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma

    doi:10.1054/bjoc.2001.2094

  • gastrocnemius muscle

    J Khal, S M Wyke, S T Russell, A V Hine and M J Tisdale

    Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia

    advance online publication, 2005-09-06 00:00:00.000;

    doi:10.1038/sj.bjc.6602780

  • gastrointestinal

    A M Grabowska, C A Berry, J Hughes, M Bushell, A E Willis and S A Watson

    A gastrin transcript expressed in gastrointestinal cancer cells contains an internal ribosome entry site

    advance online publication, 2008-04-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604326

  • K A Gurney, R A Cartwright and E A Gilman

    Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry

    doi:10.1038/sj.bjc.6690307

  • gastrointestinal cancer

    R-D Hofheinz, J T Hartmann, A Willer, K Oechsle, G Hartung, U Gnad, S Saussele, S Kreil, C Bokemeyer, R Hehlmann and A Hochhaus

    Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

    advance online publication, 2004-07-06 00:00:00.000;

    doi:10.1038/sj.bjc.6602025

  • A M Grabowska, J Hughes and S A Watson

    Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603588

  • Y Fukuyoshi, H Inoue, Y Kita, T Utsunomiya, T Ishida and M Mori

    EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers

    advance online publication, 2008-04-15 00:00:00.000;

    doi:10.1038/sj.bjc.6604341

  • M Mori, T Shiraishi, S Tanaka, M Yamagata, K Mafune, Y Tanaka, H Ueo, G F Barnard and K Sugimachi

    Lack of DMBT1 expression in oesophageal, gastric and colon cancers

    doi:10.1038/sj.bjc.6690035

  • D C McMillan, P O'Gorman and C S McArdle

    A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

    doi:10.1038/sj.bjc.6690077

  • gastrointestinal neoplasms

    S E Duff, C Li, M Jeziorska, S Kumar, M P Saunders, D Sherlock, S T O'Dwyer and G C Jayson

    Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy

    doi:10.1038/sj.bjc.6601145

  • gastrointestinal stromal tumours

    P Bümming, J Andersson, J M Meis-Kindblom, H Klingenstierna, K Engström, U Stierner, B Wängberg, S Jansson, H Ahlman, L-G Kindblom and B Nilsson

    Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

    doi:10.1038/sj.bjc.6600965

  • M Salto-Tellez, M E Nga, H C Han, A S-C Wong, C K Lee, D Anuar, S S Ng, M Ho, A Wee, Y H Chan and R Soong

    Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours

    advance online publication, 2007-02-13 00:00:00.000;

    doi:10.1038/sj.bjc.6603551

  • A Hoeben, P Schöffski and M Debiec-Rychter

    Clinical implications of mutational analysis in gastrointestinal stromal tumours

    advance online publication, 2008-02-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604217

  • I Contreras-Hernández, J F Mould-Quevedo, A Silva, G Salinas-Escudero, M A Villasís-Keever, V Granados-García, G Dávila-Loaiza, J A Petersen and J Garduño-Espinosa

    A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours

    advance online publication, 2008-05-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604367

  • gastrointestinal tract

    A-M Jakobsen, H Ahlman, L Kölby, J Abrahamsson, R Fischer-Colbrie and O Nilsson

    NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids

    doi:10.1038/sj.bjc.6600924

  • gastrointestinal tumour

    H Dote, S Toyooka, K Tsukuda, M Yano, T Ota, M Murakami, M Naito, M Toyota, A F Gazdar and N Shimizu

    Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour

    advance online publication, 2005-03-15 00:00:00.000;

    doi:10.1038/sj.bjc.6602458

  • N Théou-Anton, S Tabone, D Brouty-Boyé, R Saffroy, L Ronnstrand, A Lemoine and J-F Emile

    Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism

    advance online publication, 2006-03-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603063

  • GDEPT

    N A Helsby, D M Ferry, A V Patterson, S M Pullen and W R Wilson

    2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT

    doi:10.1038/sj.bjc.6601612

  • X Guo, T R J Evans, S Somanath, A L Armesilla, J L Darling, A Schatzlein, J Cassidy and W Wang

    In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer–promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines

    advance online publication, 2007-08-07 00:00:00.000;

    doi:10.1038/sj.bjc.6603930